AbbVie Sues Generic Drugmaker Sun Over Zemplar Patent

Jan. 25, 2013

By Phil Milford

AbbVie Inc. (ABBV), the drug unit that split from parent Abbott Laboratories (ABT) on Jan. 1, sued Indian generic drugmaker Sun Pharmaceutical Industries Ltd. for infringing a patent for Zemplar, used to treat kidney patients.

Read this complete story at Bloomberg.